Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label ritlecitinib study in alopecia areata (Japan)
jRCT2080224919Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2019
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of ritlecitinib tosilate in alopecia areata, sponsored by Pfizer. Started Oct 2019; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on jRCT2080224919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224919.